Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 405Brain Neoplasms 163Glioma 159Gliosarcoma 128Astrocytoma 115Central Nervous System Neoplasms 110Oligodendroglioma 74Neuroblastoma 44Medulloblastoma 33Ependymoma 26Recurrence 23Neoplasms 19Neoplasm Metastasis 16Diffuse Intrinsic Pontine Glioma 15Choroid Plexus Neoplasms 13Optic Nerve Glioma 11Melanoma 11Spinal Cord Neoplasms 10Rhabdoid Tumor 10Lymphoma 9Familial ependymoma 9Rhabdomyosarcoma 8Osteosarcoma 8Neuroectodermal Tumors, Primitive 8Breast Neoplasms 8Sarcoma, Ewing 6Sarcoma 6Pinealoma 6Neuroectodermal Tumors, Primitive, Peripheral 6Glioma, Subependymal 6

Interventions

Bevacizumab 3contrast agent BR1 2Oncolytic Virotherapy 2vorasidenib 1pembrolizumab 1keyhole-limpet hemocyanin 1interferon gamma-1b 1Vaccines 1Temozolomide 1Stem Cell Transplantation 1Microbubbles 1Interleukin-12 1Interferon-gamma 1Immunotherapy 1Biopsy 1Antibodies, Monoclonal 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Nerve Tissue × Temozolomide × CNS × Clear all
NCT04388033 2020-06-09

Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1/2 Unknown
10 enrolled
CNS

Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Neoplasms, Neuroepithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡